(Q41151023)

27 September 2017

title

Insulin-Like Growth Factors (IGFs) and IGF Binding Proteins in Chronic Renal Failure: Evidence for Reduced Secretion of IGFs (English)

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

1 December 2022

author name string

W. F. Blum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1815456

1 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1815456

1 December 2022

publication date

1 January 1991

1 reference

full work available at URL

27 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.1991.tb12039.x

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1651-2227.1991.tb12039.x/fullpdf

1 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Acta Paediatrica Scandinavica. Supplement

1 December 2022

published in

1 reference

27 September 2017

volume

379

1 reference

27 September 2017

page(s)

24-31; discussion 32

1 reference

Somatomedin in growth disorders and chronic renal insufficiency in children

27 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Somatomedin activity and inorganic sulfate in children undergoing hemodialysis

1 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Somatomedin inhibitor in uremia

1 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia

1 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

A Specific Radioimmunoassay for the Growth Hormone (GH)-Dependent Somatomedin-Binding Protein: Its Use for Diagnosis of GH Deficiency

1 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex

1 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure

1 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum

1 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

IGF binding proteins in growth-retarded children with chronic renal failure

1 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Characterization of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure

1 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding

1 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma

1 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex-matched normal subjects.

1 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure.

1 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease

1 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1651-2227.1991.TB12039.X

1 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1815456

1 December 2022

1 reference